Recursion Pharmaceuticals
Recursion Pharmaceuticals Inc is an American clinical-stage biotechnology company deploying machine learning for drug discovery. The company operates the Recursion OS, an integrated platform combining automated biology and chemistry data with artificial intelligence models to discover novel therapeutics. Revenue is principally derived from strategic biopharmaceutical research collaborations, licensing agreements, and technology partnerships. Core end markets encompass oncology, rare genetic diseases, and infectious disease sectors within global healthcare. Recursion holds a prominent position as a pioneer in AI-driven drug discovery with an expanding clinical pipeline. The company is headquartered in Salt Lake City, Utah, and its Class A common stock trades on the Nasdaq Global Select Market.
4 of the funds FundTelligence covers report a position in Recursion Pharmaceuticals.
- Legal name
- Recursion Pharmaceuticals Inc
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 4
- Exposure themes
- Artificial Intelligence, Drug Discovery & Design, Healthcare
Funds holding Recursion Pharmaceuticals
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.18 % (full portfolio disclosed, October 2026)
- BlackRock iShares NASDAQ US Biotechnology UCITS ETF — BlackRock · 0.12 % (full portfolio disclosed, October 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)